Showing 1321-1330 of 2028 results for "".
- AestheticsWire Exclusive: Meet Allē, Allergan’s Upgraded Patient Loyalty Programhttps://modernaesthetics.com/news/aestheticswire-exclusive-meet-alle-allergans-upgraded-patient-loyalty-program/2472858/Allergan’s Brilliant Distinctions customer loyalty program is getting a facelift in honor of its 2nd decade. The program is smarter, faster and now goes by Allē. It’s much more than a new name, shares Carrie Strom, Allergan’s Senior Vice President o
- BTL Files Patent Infringement Lawsuit Against Allergan and Zimmer Related to Emsculpthttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-allergan-and-zimmer-related-to-emsculpt/2472855/BTL Aesthetics' US affiliate has filed a lawsuit against Allergan plc, Ireland and its affiliates, and Zimmer MedizinSysteme GmbH, Germany, and its affiliate, in the US Federal District Court for the District of Delaware. The lawsuit asserts
- Lutronic Introduces the Most Powerful Thulium Laser to Receive FDA Clearancehttps://modernaesthetics.com/news/lutronic-introduces-the-most-powerful-thulium-laser-to-receive-fda-clearance/2472852/Lutronic unveiled the new LaseMD ULTRA™ during live patient demonstrations at the Cosmetic Surgery Forum in Nashville, TN. The LaseMD ULTRA offersthe highest available power that allows for fast treatments, customizable for multiple areas. Additionally, the system providesgen
- Cutera Launches Heroes Among Us Programhttps://modernaesthetics.com/news/cutera-launches-heroes-among-us-program/2472851/Cutera is launching its new “Heroes Among Us” program to showcase patients who’ve been positively affected by Cutera technologies. The new program was launched at the Cutera University Clinical
- It's A Deal: Baring Private Equity Asia Agrees to Acquire Lumenishttps://modernaesthetics.com/news/its-a-deal-baring-private-equity-asia-agrees-to-acquire-lumenis/2472848/Baring Private Equity Asia’s affiliated private equity funds are acquiring Lumenis. The transaction, which values Lumenis at an enterprise value of more than $1 billion, remains subject to the customary regulatory approval process. It is expected to be completed in early 2020. <
- Dr. Roy Geronemus Awarded the Vic Narurkar, MD Innovations in Aesthetic Dermatology Lectureship Awardhttps://modernaesthetics.com/news/dr-roy-geronemus-awarded-the-vic-narurkar-md-innovations-in-aesthetic-dermatology-lectureship-award-1/2472843/Roy Geronemus, MD of Laser & Skin Surgery Center of New York received, The American Society for Dermatologic Surgery inaugural Vic Narurkar, M.D., Innovations in Aesthetic Dermatology Lectureship Award Dr. Geronemus received the award at the 2019 ASDS annual meeting in Chicago. He d
- Madam President: Dr. Mary Lynn Moran Takes the Helm at AAFPRShttps://modernaesthetics.com/news/madam-president-dr-mary-lynn-moran-is-the-new-aafprs-president/2472834/Franklin, TN-based facial plastic surgeon Mary Lynn Moran, MD, is the new President of The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS). Dr. Moran, who will serve the 2019-2020 year term, is the first female to serve as AAFPRS president. “My goa
- British Plastic Surgeons to Vote on Brazilian Butt Lift Banhttps://modernaesthetics.com/news/british-plastic-surgeons-to-vote-on-brazilian-butt-lift-ban/2472830/It’s been called the deadliest cosmetic surgery procedure in the world, and now the British Association of Aesthetic Plastic Surgeons (BAAPS) is launching a formal safety review of Brazilian butt lifts that will culminate with a vote on whether to ban fat grafting buttock augmentation.
- AAFE Launches Medspa Business Academy (MBA)https://modernaesthetics.com/news/aafe-launches-medspa-business-academy-mba/2472828/The American Academy of Facial Esthetics (AAFE) has launched its Medspa Business Academy (MBA) with the goal to assist esthetic medical/dental practices and medical spas across the country in building a successful injectable practice and medical spa business. Early registration discount
- Results of Phase 2 Study Demonstrate Safety and Efficacy of Galderma's Proprietary Liquid Toxinhttps://modernaesthetics.com/news/results-of-phase-2-study-demonstrate-safety-and-efficacy-of-galdermas-proprietary-liquid/2472827/Results of a Phase 2 study show Galderma’s novel liquid abotulinum toxin, QM1114, is safe and effective for the treatment of glabellar lines. Galderma is now poised to advance to Phase 3 testing of the liquid formulation of botulinum toxin type A for the treatment of glabellar lines. The tr